New approaches and therapeutic modalities for the treatment of patients with chronic hepatitis C.
A major challenge in the field of hepatology is the fight against hepatitis C that affects more than 150 million people world-wide. Despite the enormous improvement that has been achieved in the therapy of chronic hepatitis C over the last decade, there is an urgent medical need for new therapeutic approaches. This review focuses on the optimization of the current standard therapy of hepatitis C and future treatment directions beyond pegylated interferon alpha and ribavirin.
Cornberg
Markus
M
Medizinische Hochschule Hannover, Department of Gastroenterology, Hepatology, and Endocrinology Carl-Neuberg Str, 1, D-3065 Hannover, Germany. cornberg.markus@mm-hannover.de
Manns
Michael P
MP
D000998:Antiviral Agents / Q000627:therapeutic use*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans
D000998:Antiviral Agents